TP53 and neoplasm: In previously published studies which reported that only mutant TP53/TRP53 expressing cells were sensitive to APR-246 [54, 55], the wt or mutant TP53 expressing human cancer cell lines tested were derived from different tumours and thus had distinct genetic backgrounds with different oncogenic driver mutations.